Plain-English translation of NCT06864338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing and testing a new stool-based test called the Mainz Biomed Colorectal Cancer Screening Test to help detect colorectal cancer and precancerous polyps early. This pilot study will enroll about 2,700 people to see how well the test works and to establish the best cut-off values for determining who might have cancer or precancerous growths. Your stool sample would help researchers improve the test's accuracy.
Current colorectal cancer screening methods like colonoscopy are effective but invasive and require preparation. This medication aims to provide an easier, non-invasive option that could catch cancer and dangerous polyps earlier, especially in people who might avoid traditional screening.
You likely qualify if…
You likely don't qualify if…
You would provide a single stool sample and have it shipped to a laboratory for testing. Your sample will be analyzed as part of the research to help develop and refine the new screening test. You will also undergo a screening colonoscopy as planned — the test results from your stool sample will not be shared with you or your doctor as part of this pilot study.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States
Sponsor
Mainz Biomed
Enrollment target
~2,700 participants
Started
December 2022
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lena Krammes, PhD
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.